sprycel
bristol-myers squibb pharma eeig - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - sprycel je primerna za zdravljenje pediatričnih bolnikov z:novo diagnosticiranih philadelphia kromosom-pozitivno kronične myelogenous levkemijo v kronično fazo (ph+ cml kt) ali ph+ cml cp odporne ali nestrpni, da pred terapijo, vključno z imatinib. na novo diagnosticirana ph+ acute lymphoblastic levkemijo (all) v kombinaciji s kemoterapijo. sprycel je indiciran za zdravljenje odraslih bolnikov z:novo diagnosticiranih philadelphia-kromosoma-pozitivne (ph+) kronična myelogenous levkemijo (cml) v kronično fazo;kronično, pospešeno ali pišu faze cml s odpornost ali nestrpnosti predhodno zdravljenje, vključno z imatinib mesilate;ph+ acute lymphoblastic levkemijo (all) in lymphoid pišu cml s odpornost ali nestrpnosti do pred terapijo. sprycel je primerna za zdravljenje pediatričnih bolnikov z:novo diagnosticirana ph+ cml v kronično fazo (ph+ cml-cp) ali ph+ cml-cp odporne ali nestrpni, da pred terapijo, vključno z imatinib.
doptelet
swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocitopenija - antihemoragije - doptelet je primerna za zdravljenje hude trombocitopenije pri odraslih bolnikih s kronično bolezen jeter, ki so načrtovani, da opravijo invaziven postopek. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikosteroidi, imunoglobulini).
dasatinib krka 100 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 100 mg / 1 tableta - dasatinib
dasatinib krka 50 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 50 mg / 1 tableta - dasatinib
dasatinib krka 70 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 70 mg / 1 tableta - dasatinib
dasatinib krka 20 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 20 mg / 1 tableta - dasatinib
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
dasatinib krka 100 mg filmsko obložene tablete
dasatinib - filmsko obložena tableta - dasatinib 100 mg / 1 tableta - dasatinib
durogesic 25 mikrogramov/h transdermalni obliž
johnson & johnson d.o.o. - fentanil - transdermalni obliž - fentanil 4,2 mg / 1 obliž - fentanil